Lahey Hospital and Medical Center, Institute of Urology, Burlington, MA.
Lahey Hospital and Medical Center, Institute of Urology, Burlington, MA.
Urology. 2020 Jun;140:178-180. doi: 10.1016/j.urology.2020.03.008. Epub 2020 Mar 17.
To evaluate our 20-year experience of urethroplasty with ventral buccal mucosa graft (BMG) and gracilis muscle flap coverage for long segment urethral strictures unfit for standard repair due to a compromised graft bed and poor vascular supply.
We retrospectively reviewed the records of 1687 patients who underwent urethroplasty at our institution between 1999 and 2019. We identified 30 patients who underwent urethroplasty with a ventral BMG and gracilis muscle flap graft bed. Stricture recurrence was defined as the inability to pass a 17-French cystoscope.
Mean stricture length was 7.6 centimeters (range 3.5-15). Strictures were located in the posterior urethra with or without involvement of the bulbar urethra in 60% of cases, the bulbomembranous urethra in 30%, the bulbar urethra in 6.7%, and the proximal pendulous urethra in 3.3%. Stricture etiology was radiation therapy in 60% of cases, prostatectomy in 23.3%, transurethral surgery in 13.3%, idiopathic in 13.3%, trauma in 10%, and hypospadias failure in 3.3%. Ten (33.3%) patients were previously treated with urethroplasty, 26 (86.7%) had prior endoscopic stricture management, and 3 (10%) previously underwent UroLume stent placement. Urethral reconstruction was successful in 23 cases (76.7%) at a mean follow-up of 32 months (range 4-92). Two of the patients in whom treatment failed underwent urinary diversion, 3 underwent suprapubic tube placement, 1 had endoscopic urethral dilation, and 1 had direct visual internal urethrotomy performed. Mean time to recurrence was 8 months (range 2-17). Postoperatively, 7 patients (23.3%) had incontinence requiring artificial urinary sphincter placement.
Ventral BMG urethroplasty with gracilis muscle flap coverage can be successfully performed for high risk, long segment urethral strictures, avoiding urinary diversion in most patients.
评估我们 20 年来使用腹侧颊黏膜移植物(BMG)和股薄肌瓣覆盖治疗因移植床受损和血供不良而不适合标准修复的长段尿道狭窄的经验。
我们回顾性分析了 1999 年至 2019 年期间在我们机构接受尿道成形术的 1687 例患者的记录,确定了 30 例接受腹侧 BMG 和股薄肌瓣移植床尿道成形术的患者。尿道狭窄复发定义为无法通过 17-French 膀胱镜。
平均狭窄长度为 7.6 厘米(范围 3.5-15)。60%的病例狭窄位于后尿道,伴有或不伴有球部尿道受累,30%的病例位于球膜部尿道,6.7%的病例位于球部尿道,3.3%的病例位于近端悬垂部尿道。狭窄病因:放疗 60%,前列腺切除术 23.3%,经尿道手术 13.3%,特发性 13.3%,外伤 10%,尿道下裂失败 3.3%。10 例(33.3%)患者曾接受尿道成形术治疗,26 例(86.7%)曾接受内镜下狭窄治疗,3 例(10%)曾行 UroLume 支架置入术。23 例(76.7%)患者在平均 32 个月(范围 4-92)的随访中尿道重建成功。2 例治疗失败的患者行尿流改道术,3 例行耻骨上管留置术,1 例行内镜下尿道扩张术,1 例行直视下尿道内切开术。复发时间平均为 8 个月(范围 2-17)。术后,7 例(23.3%)患者出现尿失禁,需行人工尿道括约肌植入术。
腹侧 BMG 尿道成形术联合股薄肌瓣覆盖可成功治疗高危、长段尿道狭窄,大多数患者可避免尿流改道。